These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 29516890)

  • 41. 1,2,3,4,8,9,10,11-octahydrobenzo[j]phenanthridine-7,12-diones as new leads against Mycobacterium tuberculosis.
    Cappoen D; Claes P; Jacobs J; Anthonissen R; Mathys V; Verschaeve L; Huygen K; De Kimpe N
    J Med Chem; 2014 Apr; 57(7):2895-907. PubMed ID: 24611928
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis and structure-activity relationships of phenyl-substituted coumarins with anti-tubercular activity that target FadD32.
    Kawate T; Iwase N; Shimizu M; Stanley SA; Wellington S; Kazyanskaya E; Hung DT
    Bioorg Med Chem Lett; 2013 Nov; 23(22):6052-9. PubMed ID: 24103299
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones.
    Castagnolo D; Manetti F; Radi M; Bechi B; Pagano M; De Logu A; Meleddu R; Saddi M; Botta M
    Bioorg Med Chem; 2009 Aug; 17(15):5716-21. PubMed ID: 19581099
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Phenotypic Based Target Screening Approach Delivers New Antitubercular CTP Synthetase Inhibitors.
    Esposito M; Szadocka S; Degiacomi G; Orena BS; Mori G; Piano V; Boldrin F; Zemanová J; Huszár S; Barros D; Ekins S; Lelièvre J; Manganelli R; Mattevi A; Pasca MR; Riccardi G; Ballell L; Mikušová K; Chiarelli LR
    ACS Infect Dis; 2017 Jun; 3(6):428-437. PubMed ID: 28475832
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and biological evaluation of dihydroquinoline carboxamide derivatives as anti-tubercular agents.
    Kumar G; Sathe A; Krishna VS; Sriram D; Jachak SM
    Eur J Med Chem; 2018 Sep; 157():1-13. PubMed ID: 30064024
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 5-Arylaminouracil Derivatives: New Inhibitors of Mycobacterium tuberculosis.
    Matyugina E; Novikov M; Babkov D; Ozerov A; Chernousova L; Andreevskaya S; Smirnova T; Karpenko I; Chizhov A; Murthu P; Lutz S; Kochetkov S; Seley-Radtke KL; Khandazhinskaya AL
    Chem Biol Drug Des; 2015 Dec; 86(6):1387-96. PubMed ID: 26061192
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of gallic acid formazans as novel enoyl acyl carrier protein reductase inhibitors for the treatment of tuberculosis.
    Saharan VD; Mahajan SS
    Bioorg Med Chem Lett; 2017 Feb; 27(4):808-815. PubMed ID: 28117201
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Design of novel dispirooxindolopyrrolidine and dispirooxindolopyrrolothiazole derivatives as potential antitubercular agents.
    Mhiri C; Boudriga S; Askri M; Knorr M; Sriram D; Yogeeswari P; Nana F; Golz C; Strohmann C
    Bioorg Med Chem Lett; 2015 Oct; 25(19):4308-13. PubMed ID: 26271585
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel N-linked aminopiperidine-based gyrase inhibitors with improved hERG and in vivo efficacy against Mycobacterium tuberculosis.
    Hameed P S; Patil V; Solapure S; Sharma U; Madhavapeddi P; Raichurkar A; Chinnapattu M; Manjrekar P; Shanbhag G; Puttur J; Shinde V; Menasinakai S; Rudrapatana S; Achar V; Awasthy D; Nandishaiah R; Humnabadkar V; Ghosh A; Narayan C; Ramya VK; Kaur P; Sharma S; Werngren J; Hoffner S; Panduga V; Kumar CN; Reddy J; Kumar K N M; Ganguly S; Bharath S; Bheemarao U; Mukherjee K; Arora U; Gaonkar S; Coulson M; Waterson D; Sambandamurthy VK; de Sousa SM
    J Med Chem; 2014 Jun; 57(11):4889-905. PubMed ID: 24809953
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of KasA as the cellular target of an anti-tubercular scaffold.
    Abrahams KA; Chung CW; Ghidelli-Disse S; Rullas J; Rebollo-López MJ; Gurcha SS; Cox JA; Mendoza A; Jiménez-Navarro E; Martínez-Martínez MS; Neu M; Shillings A; Homes P; Argyrou A; Casanueva R; Loman NJ; Moynihan PJ; Lelièvre J; Selenski C; Axtman M; Kremer L; Bantscheff M; Angulo-Barturen I; Izquierdo MC; Cammack NC; Drewes G; Ballell L; Barros D; Besra GS; Bates RH
    Nat Commun; 2016 Sep; 7():12581. PubMed ID: 27581223
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and antituberculosis activity of a novel series of optically active 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles.
    Sasaki H; Haraguchi Y; Itotani M; Kuroda H; Hashizume H; Tomishige T; Kawasaki M; Matsumoto M; Komatsu M; Tsubouchi H
    J Med Chem; 2006 Dec; 49(26):7854-60. PubMed ID: 17181168
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New class of methyl tetrazole based hybrid of (Z)-5-benzylidene-2-(piperazin-1-yl)thiazol-4(%H)-one as potent antitubercular agents.
    Chauhan K; Sharma M; Trivedi P; Chaturvedi V; Chauhan PM
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4166-70. PubMed ID: 25127167
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and antitubercular evaluation of 4-carbonyl piperazine substituted 1,3-benzothiazin-4-one derivatives.
    Peng CT; Gao C; Wang NY; You XY; Zhang LD; Zhu YX; Xv Y; Zuo WQ; Ran K; Deng HX; Lei Q; Xiao KJ; Yu LT
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1373-6. PubMed ID: 25754492
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aminopyrazolo[1,5-a]pyrimidines as potential inhibitors of Mycobacterium tuberculosis: Structure activity relationships and ADME characterization.
    Soares de Melo C; Feng TS; van der Westhuyzen R; Gessner RK; Street LJ; Morgans GL; Warner DF; Moosa A; Naran K; Lawrence N; Boshoff HI; Barry CE; Harris CJ; Gordon R; Chibale K
    Bioorg Med Chem; 2015 Nov; 23(22):7240-50. PubMed ID: 26522089
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel Cephalosporins Selectively Active on Nonreplicating Mycobacterium tuberculosis.
    Gold B; Smith R; Nguyen Q; Roberts J; Ling Y; Lopez Quezada L; Somersan S; Warrier T; Little D; Pingle M; Zhang D; Ballinger E; Zimmerman M; Dartois V; Hanson P; Mitscher LA; Porubsky P; Rogers S; Schoenen FJ; Nathan C; Aubé J
    J Med Chem; 2016 Jul; 59(13):6027-44. PubMed ID: 27144688
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Elaboration of a proprietary thymidylate kinase inhibitor motif towards anti-tuberculosis agents.
    Song L; Risseeuw MDP; Froeyen M; Karalic I; Goeman J; Cappoen D; Van der Eycken J; Cos P; Munier-Lehmann H; Van Calenbergh S
    Bioorg Med Chem; 2016 Nov; 24(21):5172-5182. PubMed ID: 27614917
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis of novel [1,2]-diamines with antituberculosis activity.
    Meng Q; Luo H; Chen Y; Wang T; Yao Q
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5372-5. PubMed ID: 19682895
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In Vitro Activity of 3-Triazeneindoles against Mycobacterium tuberculosis and Mycobacterium avium.
    Nikonenko BV; Kornienko A; Majorov K; Ivanov P; Kondratieva T; Korotetskaya M; Apt AS; Salina E; Velezheva V
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6422-4. PubMed ID: 27503657
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and in vitro antitubercular activity of a series of quinoline derivatives.
    de Souza MV; Pais KC; Kaiser CR; Peralta MA; de L Ferreira M; Lourenço MC
    Bioorg Med Chem; 2009 Feb; 17(4):1474-80. PubMed ID: 19188070
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification and optimization of a new series of anti-tubercular quinazolinones.
    Couturier C; Lair C; Pellet A; Upton A; Kaneko T; Perron C; Cogo E; Menegotto J; Bauer A; Scheiper B; Lagrange S; Bacqué E
    Bioorg Med Chem Lett; 2016 Nov; 26(21):5290-5299. PubMed ID: 27671498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.